GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » RBC Bioscience Corp (ROCO:6848) » Definitions » Total Assets

RBC Bioscience (ROCO:6848) Total Assets : NT$753.8 Mil (As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is RBC Bioscience Total Assets?

RBC Bioscience's Total Assets for the quarter that ended in Dec. 2023 was NT$753.8 Mil.

During the past 12 months, RBC Bioscience's average Total Assets Growth Rate was -3.60% per year. During the past 3 years, the average Total Assets Growth Rate was 27.90% per year. During the past 5 years, the average Total Assets Growth Rate was 45.70% per year.

During the past 7 years, RBC Bioscience's highest 3-Year average Total Assets Growth Rate was 71.30%. The lowest was 27.90%. And the median was 68.50%.

Total Assets is connected with ROA %. RBC Bioscience's annualized ROA % for the quarter that ended in Dec. 2023 was 1.09%. Total Assets is also linked to Revenue through Asset Turnover. RBC Bioscience's Asset Turnover for the quarter that ended in Dec. 2023 was 0.11.


RBC Bioscience Total Assets Historical Data

The historical data trend for RBC Bioscience's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

RBC Bioscience Total Assets Chart

RBC Bioscience Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Total Assets
Get a 7-Day Free Trial 200.95 512.62 847.60 790.55 753.79

RBC Bioscience Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Total Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only 847.60 816.95 790.55 763.19 753.79

RBC Bioscience Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

RBC Bioscience's Total Assets for the fiscal year that ended in Dec. 2023 is calculated as

Total Assets=Total Equity (A: Dec. 2023 )+Total Liabilities (A: Dec. 2023 )
=240.709+513.081
=753.8

RBC Bioscience's Total Assets for the quarter that ended in Dec. 2023 is calculated as

Total Assets=Total Equity (Q: Dec. 2023 )+Total Liabilities (Q: Dec. 2023 )
=240.709+513.081
=753.8

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


RBC Bioscience  (ROCO:6848) Total Assets Explanation

Total Assets is connected with ROA %.

RBC Bioscience's annualized ROA % for the quarter that ended in Dec. 2023 is

ROA %=Net Income (Q: Dec. 2023 )/( (Total Assets (Q: Jun. 2023 )+Total Assets (Q: Dec. 2023 ))/ count )
=8.248/( (763.194+753.79)/ 2 )
=8.248/758.492
=1.09 %

Note: The Net Income data used here is two times the semi-annual (Dec. 2023) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

RBC Bioscience's Asset Turnover for the quarter that ended in Dec. 2023 is

Asset Turnover
=Revenue (Q: Dec. 2023 )/( (Total Assets (Q: Jun. 2023 )+Total Assets (Q: Dec. 2023 ))/ count )
=83.527/( (763.194+753.79)/ 2 )
=83.527/758.492
=0.11

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

RBC Bioscience Total Assets Related Terms

Thank you for viewing the detailed overview of RBC Bioscience's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


RBC Bioscience (ROCO:6848) Business Description

Traded in Other Exchanges
N/A
Address
Lane 235, Baoqiao Road, 3rd Floor, No. 132, New Taipei City, TWN, 23145
RBC Bioscience Corp is a bio sciences company. Its products include Real Genomics, MagCore Automated Nucleic Acid Extractor, and MagCore Nucleic Acid Extraction KIT.

RBC Bioscience (ROCO:6848) Headlines

No Headlines